HRES 279
112th Congress
House
Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Agreed to (House)
Jun 3, 2011
Referred to the Subcommittee on Health.
May 25, 2011
Referred to the House Committee on Energy and Commerce.
May 25, 2011
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). H. Res. 279: Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.. 112th Congress. Open America. https://openamerica.io/bill/112-HRES-279/
"H. Res. 279: Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-HRES-279/.
H. Res. 279, 112th Cong. (2026), https://openamerica.io/bill/112-HRES-279/.
[H. Res. 279: Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.](https://openamerica.io/bill/112-HRES-279/)